Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Madhumita Shrotri, Annalan M D Navaratnam, Vincent Nguyen, et al.
The Lancet (2021) Vol. 398, Iss. 10298, pp. 385-387
Open Access | Times Cited: 402

Showing 1-25 of 402 citing articles:

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
E G Levin, Yaniv Lustig, Carmit Cohen, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 1083
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
Michela Antonelli, Rose Penfold, Jordi Merino, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 1, pp. 43-55
Open Access | Times Cited: 466
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
Nick Andrews, Elise Tessier, Julia Stowe, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 4, pp. 340-350
Open Access | Times Cited: 379
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Peter Nordström, Marcel Ballin, Anna Nordström
The Lancet (2022) Vol. 399, Iss. 10327, pp. 814-823
Open Access | Times Cited: 278
Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
Barak Mizrahi, Roni Lotan, Nir Kalkstein, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 250
COVID-19 vaccination: The road ahead
Daniel M. Altmann, Rosemary J. Boyton
Science (2022) Vol. 375, Iss. 6585, pp. 1127-1132
Closed Access | Times Cited: 180
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
Sivan Gazit, Roei Shlezinger, Galit Perez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 177
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113008-113008
Open Access | Times Cited: 149
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Vaccines (2021) Vol. 9, Iss. 11, pp. 1286-1286
Open Access | Times Cited: 148
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
Tal Patalon, Sivan Gazit, Virginia E. Pitzer, et al.
JAMA Internal Medicine (2021) Vol. 182, Iss. 2, pp. 179-179
Open Access | Times Cited: 144
COVID‐19 Vaccine Response in People with Multiple Sclerosis
Emma Tallantyre, Nicola Vickaryous, Valerie Anderson, et al.
Annals of Neurology (2021) Vol. 91, Iss. 1, pp. 89-100
Open Access | Times Cited: 143
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events
Siew C. Ng, Ye Peng, Lin Zhang, et al.
Gut (2022) Vol. 71, Iss. 6, pp. 1106-1116
Open Access | Times Cited: 139
Population antibody responses following COVID-19 vaccination in 212,102 individuals
Helen Ward, Matthew Whitaker, Barnaby Flower, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 135
Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine
Yihao Liu, Qin Zeng, Caiguanxi Deng, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 122
Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2939-2961
Open Access | Times Cited: 116
COVID vaccine boosters: the most important questions
Ewen Callaway
Nature (2021) Vol. 596, Iss. 7871, pp. 178-180
Open Access | Times Cited: 113
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers
Jean‐Louis Bayart, Jonathan Douxfils, Constant Gillot, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1092-1092
Open Access | Times Cited: 113
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
Qiaoli Peng, Runhong Zhou, Yuewen Wang, et al.
EBioMedicine (2022) Vol. 77, pp. 103904-103904
Open Access | Times Cited: 113
COVID-19 Vaccine Booster: To Boost or Not to Boost
Rahul Shekhar, Ishan Garg, Suman Pal, et al.
Infectious Disease Reports (2021) Vol. 13, Iss. 4, pp. 924-929
Open Access | Times Cited: 104
Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study
Sivan Gazit, Yaki Saciuk, Galit Perez, et al.
BMJ (2022), pp. e071113-e071113
Open Access | Times Cited: 80
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 71
Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The role of G-quadruplexes, exosomes and microRNAs
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 69
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 67
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top